Short description
Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.
Description
Pulmocide Ltd, a company focused on the discovery and development of a new generation of inhaled medicines for the treatment of serious viral and fungal infections of the respiratory tract.
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
London, England, United Kingdom, Europe
Founded on
January 1, 2013
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
No Way, Uh Ohhhh, Noaccess, No Way, Noaccess, Noway Youcantaccess, No Way, Noaccess, Absolutely Noaccess, Nopepepe, Absolutely Noaccess, No Way, Uh Ohhhh, Noaccess, No Way
Sign in for full access
Founders
Garth Rapeport, Pete Strong